WallStSmart
HURA

TuHURA Biosciences Inc

NASDAQ: HURA · HEALTHCARE · BIOTECHNOLOGY

$2.10
-1.41% today

Updated 2026-04-29

Market cap
$141.14M
P/E ratio
P/S ratio
EPS (TTM)
$-0.63
Dividend yield
52W range
$0 – $4
Volume
1.1M

TuHURA Biosciences Inc (HURA) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201020112012201420152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00
Revenue growth (YoY)
Cost of revenue$10288.00$16683.00$24528.00$16348.00$10000.00$32000.00$60000.00$60000.00$55000.00$116710.00
Gross profit$-10288.00$-16683.00$-24528.00$-16348.00$-10000.00$-32000.00$-60000.00$-60000.00$-55000.00$-116710.00
Gross margin
R&D$2.34M$2.56M$3.36M$5.00M$7.13M$3.66M$3.63M$11.81M$15.17M$9.31M$2.66M$13.34M
SG&A$2.38M$2.01M$4.14M$4.31M
Operating income$-5582.00$-33136.00$-18885.00$-6.29M$-4.72M$-6.21M$-8.32M$-11.17M$-8.40M$-8.14M$-21.57M$-22.68M$-14.80M$-8.45M$-17.65M
Operating margin
EBITDA$-5582.00$-33136.00$-18885.00$-8.28M$-4.35M$-8.85M$-8.07M$-11.11M$-8.03M$-9.12M$-38.15M$-22.62M$-14.74M$-8.27M$-17.43M
EBITDA margin
EBIT$-5582.00$-33136.00$-18885.00$-6.29M$-4.72M$-8.86M$-8.08M$-11.14M$-8.05M$-9.13M$-38.18M$-22.68M$-14.80M$-8.32M$-17.54M
Interest expense$8020.00$2091.00$120000.00$629286.00$0.00$18688.00$4.14M
Income tax$-1.00
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-5582.00$-33136.00$-18885.00$-8.29M$-4.35M$-8.86M$-8.08M$-11.14M$-8.05M$-9.13M$-38.30M$-22.66M$-14.65M$-8.32M$-21.68M
Net income growth (YoY)-493.6%+43.0%-43800.9%+47.6%-103.9%+8.8%-37.8%+27.7%-13.4%-319.7%+40.8%+35.4%+43.2%-160.6%
Profit margin